2019
DOI: 10.1016/j.ijcard.2019.03.023
|View full text |Cite
|
Sign up to set email alerts
|

The ACEF score in patients undergoing percutaneous coronary intervention: “Keep it simple and focus on what matters”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…11 Although the ACEF score is very simple, its predictive ability is not inferior to traditional models. 12 In addition, N-terminal pro-B-type natriuretic peptide (NT-proBNP), which is synthesized in cardiomyocytes and released into the circulation, was reported to be a potential biomarker for risk stratification in both ACS patients 13,14 and patients with three-vessel disease. 15 In addition, NT-proBNP can improve the discrimination and reclassification of the C-ACS risk score in ACS patients 16 and of the SYNTAX score II for mortality prediction in patients with three-vessel disease.…”
Section: Introductionmentioning
confidence: 99%
“…11 Although the ACEF score is very simple, its predictive ability is not inferior to traditional models. 12 In addition, N-terminal pro-B-type natriuretic peptide (NT-proBNP), which is synthesized in cardiomyocytes and released into the circulation, was reported to be a potential biomarker for risk stratification in both ACS patients 13,14 and patients with three-vessel disease. 15 In addition, NT-proBNP can improve the discrimination and reclassification of the C-ACS risk score in ACS patients 16 and of the SYNTAX score II for mortality prediction in patients with three-vessel disease.…”
Section: Introductionmentioning
confidence: 99%